Investigación médica
Últimos proyectos y avances científicos.
Multidisciplinary collaborations in medical research: an integrated approach to medical advancesApril 15, 2024- Colaboraciones Multidisciplinarias en Investigación Médica: Un Enfoque Integral para Avances MédicosApril 15, 2024
The importance of clinical trials in modern medicineMarch 15, 2024- La Importancia de los Ensayos Clínicos en la Medicina ModernaMarch 15, 2024
An option to modify the course of Parkinson’s progressionNovember 21, 2023- An option for patients with Parkinson’s and LRRK2 mutationNovember 21, 2023
- Positive result from the Pivotal trial with levodopa administered by continuous subcutaneous infusionMay 8, 2023
- New inhaled levodopa INBRIJA authorised in SpainMay 8, 2023
new drug for early-stage Alzheimer’s diseaseJanuary 16, 2023
The “passive vaccine” against Alzheimer’s disease has a “surprisingly high” efficacy, according to Dr Ernest BalaguerOctober 28, 2022- The Clarity AD clinical trial has shown a 27% reduction in cognitive decline in patients with Alzheimer’s diseaseSeptember 30, 2022
HUGC Includes World’s First Patient in New Alzheimer’s Clinical TrialJune 8, 2021- HUGC Includes Patients in Phase I REASON Trial in Parkinson’sJune 8, 2021
We tested a drug to treat agitation in Alzheimer’s patientsJune 3, 2021- FDA approves sublingual apomorphine in off periodsJuly 22, 2020
US authorizes an intranasal levodopa.April 8, 2020
Levodopa infusion pumpApril 2, 2020- Activation of phase I trial in Progressive Supranuclear PalsyMarch 11, 2020
- We continue a phase I clinical trial in ParkinsonMarch 5, 2020
The General Hospital of Catalonia, the first hospital in Spain to be activated for the phase I trial at Parkinson’s REASONJanuary 17, 2020
An amazing Phase I trial in ParkinsonJanuary 9, 2020
Our clinical trials unit remains in prominent positionJanuary 9, 2020
Positive result of the GRIFOLS trial in Alzheimer’sDecember 12, 2019- Tavapadon (Cerevel): A very different dopamine agonistNovember 29, 2019
- An innovative and surprising therapy in Parkinson’s diseaseNovember 29, 2019
- Subcutaneous levodopa infusion pump in advanced ParkinsonNovember 14, 2019
Biogen will request the approval to FDA of a new drug in early Alzheimer’s disease.November 12, 2019
A new algorithm allows to identify the people with more Alzheimer’s riskNovember 5, 2019
The General University Hospital of Catalonia, a reference in Alzheimer’s researchOctober 31, 2019- Dr. Balaguer of the General University Hospital of Catalonia talks about Alzheimer’s diseaseOctober 30, 2019
- Dental germ in patients with moderate Alzheimer’s diseaseOctober 29, 2019
- Our Parkinson’s and Alzheimer’s research unitOctober 28, 2019
- New clinical trials are looking for a cure to avoid 100 million of new patients in 2050.October 23, 2019
- Dental infection and Alzheimer’s diseaseSeptember 5, 2019
Another terapeutic target in Alzheimer diseaseMay 9, 2019- Novel contribution to the treatment of motor fluctuations in Parkinson’sMarch 27, 2019
- New antidiskinetic therapy in Parkinson’s diseaseMarch 20, 2019
Advanced Parkinson’s disease treated with a levodopa pumpMarch 20, 2019- New phase I clinical trial in early Parkinson’s.February 7, 2019
The General Hospital of Catalonia participates in a study to slow the progression of Parkinson’s diseaseJanuary 18, 2019- The Hospital Universitari General de Catalunya evaluates a new drug to correct Parkinson’s symptomsJanuary 18, 2019